Logo image
Automated detection of diabetic retinopathy: barriers to translation into clinical practice
Journal article   Peer reviewed

Automated detection of diabetic retinopathy: barriers to translation into clinical practice

Michael D Abramoff, Meindert Niemeijer and Stephen R Russell
Expert Review of Medical Devices, Vol.7(2), pp.287-296
03/01/2010
DOI: 10.1586/erd.09.76
PMCID: PMC2911785
PMID: 20214432
url
https://www.ncbi.nlm.nih.gov/pmc/articles/2911785View
Open Access

Abstract

Automated identification of diabetic retinopathy (DR), the primary cause of blindness and visual loss for those aged 18-65 years, from color images of the retina has enormous potential to increase the quality, cost-effectiveness and accessibility of preventative care for people with diabetes. Through advanced image analysis techniques, retinal images are analyzed for abnormalities that define and correlate with the severity of DR. Translating automated DR detection into clinical practice will require surmounting scientific and nonscientific barriers. Scientific concerns, such as DR detection limits compared with human experts, can be studied and measured. Ethical, legal and political issues can be addressed, but are difficult or impossible to measure. The primary objective of this review is to survey the methods, potential benefits and limitations of automated detection in order to better manage translation into clinical practice, based on extensive experience with the systems we have developed.
eye expert system complication screening blindness retina retinopathy automated diagnosis early detection diabetes image analysis prevention

Details

Metrics

Logo image